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The diagnosis of childhood pulmonary tuberculosis (TB) can be notoriously 
difficult. The chest X-ray (CXR) is a significant diagnostic resource in the detection 
of PTB in children. However, non-specific radiological features combined with 
variable inter-observer assessments contribute to diagnostic uncertainty. The CXR 
would be of most value when used specifically to evaluate those features of 
childhood TB that it shows best and where expert observers agree, namely those 
signs indicating lymphadenopathy.  
 
AIM:  
To identify simple and reliable CXR features of primary TB in children by 
determining signs and anatomical sites of best observer agreement. 
 
METHOD:  
This is a retrospective descriptive study within a clinical trial performed by the 
South African TB Vaccine Initiative (SATVI). Healthy BCG-vaccinated newborn 
infants in a high TB prevalence rural area in Worcester, near Cape Town, South 
Africa, were followed for a minimum of two years for possible incidental pulmonary 
TB. Three independent, blinded, expert paediatric radiologists reported the 
resultant CXR images using a standardised data collection tick sheet, on which the 
specific anatomical sites and signs of pathology consistent with pulmonary TB 
were recorded. The first 200 original data collection tick sheets were sampled and 
recorded in a pre-compiled data spreadsheet for our study. The sampled data 




The overall combined agreement for airway compression (by presumed 
lymphadenopathy) was 0.5%. Five % of the CXR’s had soft tissue densities 
reflecting lymphadenopathy on the frontal view and 5% on the lateral view. The 
most common site reflecting lymphadenopathy through airway narrowing or 
displacement was the left main bronchus. The hilar region (kappa 0.27) on the 
frontal CXR and behind bronchus intermedius (kappa 0.18) on the lateral were the 
most common sites of soft tissue densities reflecting lymphadenopathy. There 
were no positive findings for cavitation or pleural effusion. The overall decisions 
reflecting PTB (lymphadenopathy or miliary) by each individual reader were 27.6% 
by Reader 1, 8.5% by Reader 2 and 24.6% by Reader 3. Abnormal findings not 
specific for PTB were found in 3.5% by Reader 1, 10.5% by Reader 2 and 3.5% by 
Reader 3. 68.3% of the radiographs were reported as normal by Reader 1, 81.9% 
by Reader 2 and 66.8% by Reader 3. Only 5% of the radiographs were found to 
be unreadable by one reader. 




The fair degree of agreement amongst expert readers suggests that the CXR 
alone is not a reliable tool for detecting pulmonary TB and should be utilised in 
conjunction with the clinical features and/or skin tests and blood results. Soft 
tissue masses rather than airway compression are a more reliable sign for 
lymphadenopathy, with the most agreed upon sites on the frontal projection for 
soft tissue mass detection being the right hilar region, followed by the left hilum. 
 ix 
Unfortunately this study could not confirm the usefulness of the CXR in 
subcategorising PTB into severe and non-severe groups due to the absence of 
any positive features for severe PTB in the selected sample. The use of prescribed 
tick-sheets with specified features for detecting lymphadenopathy did not have the 
expected impact of promoting interobserver consensus of CXR findings in children 
in terms of detection of TB. The absence of a credible reference standard for 
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Diagnosing childhood pulmonary tuberculosis (PTB) is known to be an incredibly 
difficult task. The chest X-ray (CXR) remains a significant diagnostic tool in the 
process of identifying PTB in the paediatric population although atypical 
radiological features combined with inconstant inter-observer assessment of 
CXR’s contribute towards the diagnostic dilemma. The CXR would be of most 
value if used specifically for the features of childhood TB that it shows best and 





Tuberculosis remains a considerable health issue in South Africa (SA) and 
worldwide [1], with rates in SA over twice those of other developing countries, and 
nearly 60 times more than the rate observed in the USA or Western Europe. TB is 
one of the most frequent notifiable communicable diseases in South Africa, 
according to the MRC National Tuberculosis Center. [1]. In 2011 the World Health 
Organisation (WHO) figures concluded that worldwide there were an estimated 8.8 
million new cases of tuberculosis, of which approximately 13% were observed in 
human immunodeficiency virus (HIV) patients. [1, 2] Global TB data from the WHO 
includes only age subsets with positive TB smears, and therefore reflects a small 
portion (8%) of the actual disease burden faced. An estimated figure of 884,019 
cases (11% of the total) within the under 15-year age group represented the global 
 2 
age-specific burden of TB in 2000. [2] Between 15 and 20% of all sub-Saharan 
Africa TB cases are children. [3]  
 
Undiagnosed and untreated TB leads to dire consequences in the paediatric 
population. This is further compounded by progression to disseminated TB. [4] 
Tuberculosis remains one of the most significant lethal infectious diseases. [2, 5] 
WHO statistics estimated 1.1 million HIV-negative deaths from tuberculosis, plus 
350,000 HIV-linked tuberculosis deaths in 2010. [2] High morbidity and mortality 
resulting from extra-pulmonary dissemination and severe TB are common findings 
in those under 3 years. [6] 
 
Note is also made of an added 3.2 million women with tuberculosis, and 320 000 
female fatalities in 2010. [1] In 2009, parental deaths due to TB resulted in 
approximately 10 million orphaned children. [1] The global increase of multi drug-
resistance in tuberculosis, leading on to extensively and totally drug-resistant 
forms pose additional daunting challenges in the management of tuberculosis, 
particularly in sub–Saharan Africa, Asia and Eastern Europe. [1, 7] The WHO 
Tuberculosis Program projects 3.5 million new cases and a minimum of 90,000 
deaths over ten years if TB is uncontrolled. [2] 
Reinforcing the confirmation of tuberculosis relies on improved tests [8, 9, 10], 
ideally applied in poorer communities without access to other means of diagnosis. 
[10] Cheaper, more accessible and accurate tests will aid tuberculosis control 
provided that there is political support for effective national tuberculosis programs. 
[10] In the interim, better use of currently available diagnostic tests such as CXR’s 
can raise detection rates and reduce tuberculosis transmission. [1] 
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1.3. Clinical Diagnosis 
1.3.1. Classical Diagnosis - Clinical Symptoms Approach 
A structured clinical approach making use of clearly defined symptoms contributes 
towards diagnostic accuracy of TB [11] and allows for patients to be categorised 
into suspected or probable TB. [12] The suspicion of paediatric PTB is raised 
when there is a history of chronic debility with coughing or pyrexia, weight loss or 
failing to thrive, poor or no recovery following measles or whooping cough, 
tiredness, wheezing [12], malnutrition, lymphadenopathy, clinical chest findings, 
large liver or spleen, meningeal signs or ascites. [12] 
Additionally, a positive Tuberculin Skin Test (TST), a suspicious CXR, caseation, 
poor response to a fortnight of antibiotics or a favourable reaction to anti-TB 
therapy with improved weight and clearance of signs is considered most 
compatible with probable TB. [13, 14] 
Paediatric TB usually presents with pulmonary parenchymal disease plus 
intrathoracic nodes in 60–80%.[12] Extra-pulmonary TB includes
lymphadenopathy (67%), central nervous system (CNS) manifestations (13%), 
pleural disease (6%), disseminated or miliary TB (5%), and bone disease (4%). 
[12] Miliary TB and TB meningitis are more often seen in under 3 year-olds or HIV
patients [15], accounting for the detection of up to half of cases of paediatric TB. 
[16] 
Paediatric tuberculosis may be detected by using symptoms in suitable risk 
categories, as shown in 2006 by Marais et al. in symptomatic HIV-negative 
children, especially in the low-risk group. [17] Houwert et al. in 1998 found the 
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WHO criteria able to strongly predict TB using the triad of persistent cough for over 
2 weeks; measurable weight loss (failing to thrive) over 3 months; and fatigue. [18] 
Marais et al. showed that well-defined symptoms measured by using a standard 
symptom-based questionnaire held diagnostic value in paediatric TB. [19] 
Sequential diagnostic algorithms can limit diagnostic uncertainty and help health 
care workers find children requiring TB treatment. [12] Non-standardised clinical 
scoring systems lack clinical validation. [20, 21] Despite their simple utility, these 
algorithms are not often used in countries with limited technology. [3] Several 
attempts to refine symptom definitions have fared poorly in groups at greatest 
hazard for severe disease, with resultant unsatisfactory outcomes. These include 
sub 3 year-old children, those with HIV and malnourishment. [3]  
 
1.3.2. Diagnosis of pulmonary TB 
 
The need for greater diagnostic certainty in the diagnosis of paediatric TB is well 
recognised [10], especially pulmonary TB as the most frequent and most 
confounding diagnosis. [10] Culture facilities are often inadequate or inaccessible 
in tuberculosis-endemic regions and therefore the diagnosis of TB is generally 
seldom microbiologically confirmed. [10] Further complicating the situation is the 
difficulty in acquisition of sputum via expectoration in younger children, as well as 
the lower diagnostic yield. Even combining smears and cultures has a less than 
50% yield, due to the scanty bacilli. [10] Despite newer methods, diagnostic 
accuracy of childhood TB remains difficult [22] and ideally needs accurate, quick 
point-of-care (POC) diagnostic tests. [1] 
The finding of PTB in small children thus currently relies on a mix of epidemiology, 
clinical presentation and CXR features. [10] The CXR continues to be valuable in 
 5 
high-burden areas. [23] The diagnosis of pulmonary TB in children also remains 
an arduous and confounding process due to the difficulties in acquisition of 
expectorated sputum and unusual radiological features. [24] 
 
1.3.3. Mycobacterial Detection and Isolation 
 
Owing to difficulties in sputum collection in young children and poor smear 
microscopy results, microbiological proof of TB is seldom attempted, even in 
populations at risk. [24] Children with PTB do not generally expectorate at will due 
to their inability to produce sputum and the distress involved with the process. [12] 
Gastric aspirates are used as an alternative for identification and M. tuberculosis 
culture without sputum samples. [25] Three sequential early morning gastric 
lavages or gastric aspirates are the usual means of obtaining mycobacteria, but 
the technique is bedeviled by low yield, the need for infrastructure and the fact that 
the low gastric pH can kill tuberculous bacilli. [26] Considering the above, it is clear 
why under 20% of paediatric TB cases have positive sputum smears or gastric 
aspirates. [12] Recent less invasive options include induction of sputum by 
sequential inhaled bronchodilator, nebulised hypertonic saline (3–5%) and then 
either suction in the nasopharynx or coughing up of lower respiratory tract mucus. 
[24] Zar et al. compared salbutamol-induced sputum induction with gastric lavage 
in HIV positive and negative infants and young children. They found that sputum 
induction was more effective at producing M. tuberculosis, and better tolerated and 
of lower risk (including in infants). [25] The intent of these other means of sampling 
is ultimately to improve yield, as a positive culture is deemed the benchmark to 
confirm TB in a symptomatic child. [13] 
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A negative culture or yields of less than 50% of M.tuberculosis often leads to a 
diagnosis based on a reactive tuberculin skin test (TST), supportive clinical 
presentation, CXR features or adult TB contact. [12] 
 
1.3.4. Smear Microscopy 
 
Developments in smear microscopy include centrifugation to concentrate 
specimens, the modified carbol fuchsin staining (for Kinyoun or Ziehl-Neelsen 
stains) with fluorescent auramine-rhodamine dye to improve accuracy and speed 
up the process. [27] However, even allowing for all these changes, the global 
sensitivity of smear microscopy is still below 15%, with the exception of older 
children presenting with more adult-like TB. [24]  
 
1.3.5. Tuberculin Skin Test (TST)  
 
The tuberculin skin test (TST), or Mantoux TST, relies on identification of a 
delayed cutaneous hypersensitivity reaction to injected protein derivative, which is 
an imprecise purified antigen mix derived from M. tuberculosis, M. bovis Bacille 
Calmette-Guerin (BCG) and other non-tuberculous mycobacteria. [28] The 
response in millimeters of induration is measured after 48 to 72 hours. [16] The 
value of the TST merely indicates an infection with a mycobacterium, without the 
ability to either affirm or discount the presence of TB. A TST is positive in a non-
BCG-vaccinated young child when skin induration is exceeds 10 mm in diameter, 
and over 15mm in a BCG-vaccinated child. A negative TST does not however 
eliminate TB as a cause. [16] Any induration (5–14mm) could also be deemed 
compatible with the disease if coupled with suspicious clinical findings and contact 
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history. [29] Procedural, administrative and interpretation errors in distinguishing 
genuine TB from the results of past BCG-inoculation and other non-TB 
mycobacteria can arise. [16, 28, 30, 31, 32]. The response is variable and 
unknown in children with incapacitating or immune compromising diseases, 
malnutrition and some viral (such as HIV) and bacterial infections. [16, 28] 
 
1.3.6. Polymerase Chain Reaction (PCR) 
 
PCR used for diagnostic testing amplifies in-vitro DNA by utilising particular DNA 
oligonucleotide sequences as ‘fishhooks’ for microorganism DNA/cDNA. PCR is 
assumed to have the ability to identify a single organism in a variety of fluids, 
including from the stomach, airways, pleura, cerebrospinal space, plasma and 
urine. Several PCR assays exceed 90% sensitivity and specificity for identifying 
pulmonary TB in adults. [16] This method of disease detection is also affordable 
and quick [33]. PCR is particularly useful in the following circumstances: (1) 
confirmation of the diagnosis in samples with negative microscopy and culture, or 
for scant samples; (2) differentiation between M. tuberculosis and atypical 
mycobacteria; (3) detection of possible genetic variants or mutations related to 
anti-mycobacterial drug resistance. [34]  
 
PCR boasts superior sensitivity compared with culture in younger children, as 
shown in many studies. In 2001, Gomez-Pastrana et al. showed a higher 
sensitivity for PCR versus culture. [35] In a group of children with highly probable 
tuberculosis, Montenegro et al. utilised a hemi nested PCR assay and reported a 
specificity of 67%, this being considerably better than Lowenstein-Jensen culture 
(54%) or staining for acid–fast bacilli (42%) [33]. 100% of smear-positive samples 
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were PCR positive, while 76.7% of negative smears were PCR positive. In 
comparison with culture, PCR sensitivity was 90.4% with a positive predictive 
value 89%. The specificity and negative predictive values were 94% and 95% 
respectively. [33] Other studies have revealed sensitivities between 4 to 80% and 
80 to 100% specificity. [34] Gomez-Pastrana et al. found 56.8% sensitivity for PCR 
of gastric or bronchoalveolar lavage in active disease and felt that nested PCR 
was both fast and sensitive for the prompt detection of paediatric TB. [35] 
Supplementary distinctive sequences of M. tuberculosis that are nonexistent in, M. 
microti, M. bovis, M. africanum and M. bovis BCG have been recommended as 
diagnostic examinations for TB. [36] 
 
PCR is exceptionally beneficial in detection of paediatric TB as sputum smears are 
frequently inadequate. [16] Difficulties related to the utilisation of PCR however 
prevail in developing countries. These include incorrect procedure in certain 
laboratories, financial constraints, the high-level equipment required, limited 
specificity, numerous samples required to optimise yield and sample cross-
contamination. [3] 
 
1.3.7. In-House Nucleic Acid Amplification (NAA) Assays 
 
NAA assays depend on the operator, the target sequence selection and the 
process of DNA removal. Analysis of paediatric results in clinically suspected TB is 
hampered by the absence of a standard reference. NAA sensitivity versus culture 
is 40–83% but it may be positive despite negative culture [24] 
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1.3.8. Adenosine Deaminase (ADA) 
Adenosine deaminase (ADA) can be elevated in pleural TB and TB meningitis in 
adults. As both these type of TB are thought to have sparse bacillary loads, ADA 
testing is useful. A 63-study meta-analysis using ADA for diagnosing tuberculous 
pleuritis showed a 0.92 sensitivity (95% CI 0.90–0.93) with 0.90 specificity (95% CI
0.89–0.91). [37]. Although some serum ADA testing for paediatric pulmonary TB
has revealed good results, it varies widely and is felt to be inferior to PCR. 
1.3.9. Serology and Antigen Detection 
Antigen identification of mycobacterial elements has largely been assessed in 
adults, with little evaluation in children [16].  Despite its speed and the fact that the 
sample need not be acquired from the site of infection, serology is not favoured in 
routine paediatric TB diagnosis. Various factors could influence the results and 
contribute to low sensitivity. These include age, other mycobacterial exposure and 
BCG vaccination. The sensitivity and specificity are antigen dependent, as well as 
hinging on the criteria used and the nature of the tuberculous infection. [34] 
Some of these serological tests focus on the composition of the antigen (e.g. Ag 
60, 38 kDa, and lipoarabinomannan / LAM), whether of recombinant or native 
origin and their chemistry (whether lipid or protein), as well as how much antigen 
purification has been undertaken and the type of immunoglobulin. Most are 
enzyme-linked immunosorbent assays (ELISA).  
10 
Hussey et al. in 1991 [38], sought serum antibodies to autoclaved M. tuberculosis 
suspension from 132 paediatric PTB cases. The test boasted a 62% sensitivity 
and specificity of 98%. Imaz et al. in 2001 [39] used recombinant 16-kDa M. 
tuberculosis antigen (re- Ag16) for the serological identification of TB in children, 
This they did by assessing IgA, IgG and IgM values, revealing enhanced antibody 
reAg16 reaction in exposed cases versus those with non-mycobacterial disease, 
with 95% specificity. Grouping of IgG and IgA assay results showed 43% positivity 
in actively infected children. [39] 
1.3.10. In Vitro Interferon-γ (IFN-γ) Release Assays (IGRA’s) 
Immune-based assays using blood specimen analysis independent of sputum has 
been the focus of new developments [40]. IGRA’s have been established as a
more specific substitute for the tuberculin skin test in identification of latent TB [13, 
30, 40]. These assays quantify interferon-gamma (IFN-γ) liberated by sensitised
lymphocytes after contact with unique M. tuberculosis antigens. For example, the 
early secreted antigen target 6 (ESTAT-6), tb7.7 and culture filtrate protein-10 [13, 
41] located on M. tuberculosis are not present on most non-TB mycobacteria
including BCG. [41] Unfortunately latent and active disease cannot be separated 
[41]. The most up-to-date types of IFN-γ assays make use of highly specific M.
tuberculosis antigens not found on BCG or other mycobacteria including M. avium. 
[40, 42] Tests such as enzyme-linked immunospot assay (ELISPOT) and 
Quantiferon TB-gold (QFT-G) have been used. [30] QFT-G and TST showed 
similar outcomes in a study done by Dogra et al. in 2007. [30] Lymphocytes 
releasing IFN-γ were seen in two-thirds of suspected paediatric TB cases in a
study done by Nicol et al. in 2005. Positive findings were more commonly found 
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with culture-proven tuberculosis. [42] ELISPOT is thus a favorable instrument for 
diagnosing tuberculosis in children. [42] Detjen et al. also highlighted IGRA’s
ability to differentiate tuberculous and non-tuberculous mycobacterial disease. [31] 
1.3.11. GeneXpert MTB/RIF System 
GeneXpert is a simplified means of integrated DNA extraction and amplification, 
needing less sample handling and operator training. Real-time PCR (rt-PCR) also 
permits TB detection and identification of resistance to Rifampicin. The technique 
multiplies part of the M. tuberculosis rpoB gene. Mutations here lead to Rifampicin 
resistance in 95% of cases. The rpoB core region is adjacent to TB-specific DNA 
sequences, allowing concurrent assessment of both TB presence and insensitivity 
to rifampicin. [43] The ease, speed and accuracy of the Xpert system is very 
advantageous when compared with culture. [11] 
Nicol et al. found that two Xpert tests doubled case-detection rates when judged 
alongside smear microscopy, leading to suggestions that this test may replace 
smear microscopy. [8]  
1.3.12. Gas Sensor Array Electronic Nose (Electronic Nose) 
An array of 14 sensors “smell” by using electrical changes induced by specific
odours. The E-Nose identified 89% of patients with positive cultures with 91% 
specificity. [11] The usefulness of the method in diagnosing paediatric TB in the 
future requires continued evaluation. [11]  
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1.3.13. Other Developments in Progress 
 
Distinct Lama glama antibodies to the 16kDa Heat Shock Protein of M. 
tuberculosis could serve as a rapid method of identifying active PTB infection by 
infrared spectroscopy of blood serum. This test has not yet been clinically used. 
[12] 
  
The use of alternating magnetic field frequencies to accelerate culture growth up 
to seven-times has been developed by Noreiko et al. [12] 
  
Gas sensor technology has also been used to measure exhaled unstable organic 
composites in the patient’s breath to detect cancer, asthma, and TB. [12] 
1.4. Imaging Diagnosis 
1.4.1. Chest X-Ray (CXR) 
 
The CXR remains a valuable diagnostic tool in the clinical evaluation of paediatric 
intrathoracic TB. [10] The prognostic values of the criteria for diagnosing TB are 
influenced by various factors. These include the clinical and CXR differences 
between adult and paediatric TB and the influence of high prevalence 
environments. [10] 
A commonly used criterion for detecting pulmonary TB in the paediatric population 
is the manifestation of lymphadenopathy on CXR [44], especially when pulmonary 
TB is already clinically suspected. [44] 
One radiological classification of TB uses the following CXR features:  
- Lymph node TB 
- Air-space parenchymal TB (consolidation)  
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- Tuberculoma 
- Miliary TB 
- Cavities 
- Pleural TB 




A disadvantage of the CXR is the radiation dose to the patient, especially if 
repeated. Children are more vulnerable to radiation from medical investigations 
because of the immature developing organs, the closer proximity of sensitive 
areas (due to shorter bodies), and the longer life ahead in which to develop 
malignancies. [45] The lateral CXR is not only an additional view but imparts 
approximately twice the radiation dose of the AP CXR. [45] 
High cost and limited accessibility also restrict the use of imaging in certain areas. 
In addition, the differences in imaging technique can affect accuracy of 
interpretation. [45]   
Furthermore, interpretation is made more difficult by the mediastinal variation on 
CXR in those under 5 years. The prominent thymus in this age group can be as 
wide as the thoracic cavity, obscuring visualisation of areas normally assessed for 
lymphadenopathy. [45] The cardiac silhouette also occupies a larger proportion of 
the chest in a child than in an adult, often masking the hila and making it almost 
impossible to evaluate the hilar points for lymphadenopathy. [45]  
 
Other issues confounding the imaging diagnosis of TB include the variable pattern 
of disease, the effects of co-morbid infections such as human immunodeficiency 
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virus (HIV) and AIDS, the inability to identify drug resistance, nonspecific 
radiographic signs, subjective interpretation with inter- and intra-observer 
variability of readers, the possibility of a normal radiograph despite having PTB, 
and the difficulty in distinguishing active from inactive disease. [45]  
 
Moyo and colleagues classified the patients in their study as ‘definite’, ‘probable’, 
‘possible’ or ‘not TB’ based on history, examination and results of investigations 
including CXR’s. [46] CXR’s were reviewed independently by a panel of three 
paediatric radiologists blinded to the clinical information, who then categorised 
findings as ‘TB present’ (CXR findings consistent with TB), and ‘TB not present’ 
(no CXR findings consistent with TB), ‘TB equivocal' (CXR findings possibly 
associated with TB but also associated with other disease) or 'CXR not readable'. 
[46] The specific signs indicating TB were noted as a compressed or displaced 
airway, soft-tissue opacities in the hilar, paratracheal and paracardiac areas, or 
miliary nodules. [46] Those diagnosed with active TB disease were started on 
curative anti-tuberculosis treatment, while those felt to have latent TB were started 
on preventive anti-tuberculosis treatment. [46] The authors suggested that case 
definitions of TB in young children should include history, clinical and radiological 
features, as there are likely to be few bacteriologically confirmed cases. [46] 
 
In children – In a study of inter-reader variability for CXR interpretation of TB in 
children by Swingler and colleagues, only ‘‘fair agreement “between individuals 
was shown. The agreement was found to be even less for the lateral projection. 
[44] In addition to these findings, they also reported that the overall diagnostic 
accuracy of expert paediatricians compared with primary level practitioners varied 
considerably and was much lower in the latter group, particularly when identifying 
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lymphadenopathy on CXR (compared with the gold standard of CT). The 
supplementary lateral radiograph did not substantially improve diagnostic 
accuracy. [44] The low level of accurate detection of lymphadenopathy even 
among expert observers implicated inadequacies related to chest radiography. 
[44] They subsequently supported tentative use of radiographic lymphadenopathy 
to diagnose tuberculosis, particularly where the other findings were ambiguous. 
[44] They also concluded that improving radiological criteria for lymphadenopathy 
on chest radiographs might enhance diagnostic accuracy. [44] Their study 
evaluated patients with suspected TB according to the WHO criteria, without 
setting CXR reading parameters in advance. They felt that a population group 
likely to have confirmed TB and readers using pre-defined criteria might have 
yielded a different result. 
In a study by Swaminathan and colleagues, children from 6 to 12 years who had 
clinical features supportive of tuberculosis were examined further. [23] They found 
that in confirmed tuberculosis (using positive gastric aspirate cultures), a 
noteworthy proportion of patients had normal CXR’s. [23] 
 
A study done in 2005 by Theart, Marais and Gie aimed to record the criteria used to 
diagnose childhood TB at primary health facilities in high-risk communities [47] They 
demonstrated that despite good agreement with current clinical guidelines, the 
diagnostic criteria were massively dependent on accurate interpretation of the CXR. 
[47] Difficult interpretation of CXR’s and their limited availability in most high-burden 
settings contributed to making this scenario problematic. [47] The study however 
maintained the CXR as a cornerstone investigation to diagnose paediatric 
pulmonary TB. [47] 
 
 16 
The 2002 study by Du Toit, Swingler and Iloni measured variations within and 
between observers in detecting large nodes on CXR in high-risk scenarios. They 
found the inter-observer agreement among paediatric pulmonologists was “fair”, 
while intra-observer agreement was “moderate”. [48]  
 
An older study presented in 1966 by Weber, Bird and Janower focused on the 
CXR features of childhood pulmonary TB, with particular emphasis on the effects 
on the tracheobronchial tree due to lymphadenopathy, as well as additional 
pulmonary opacities. [49] 
 
In adults – In a study performed on adults older than 15 years, Den Boon and 
colleagues in testing a Chest Radiograph Reading and Recording System (CRRS) 
found good inter-reader agreement and excellent intra-reader agreement for TB-
related abnormalities. [50] They concluded that the CRRS may be of value in the 
setting of large-scale TB-prevalence reviews and projects involving community 
respiratory disease. [50] They also proposed that although chest radiography 
could be considered better as a TB screening instrument, further evaluation 
regarding the process of evaluation and interpretation was required. [50] 
 
Van Cleeff and colleagues demonstrated a low specificity of the CXR for the 
diagnosis of TB. [51] They advocated that the use of a precise rating system, 
clinical consensus and radiographic quality control could enhance the quality of 
diagnostic interpretation. [51]  
 
Zellweger and colleagues concluded that CXR screening for TB based on a 
simplified code of interpretation is reliable and reproducible, particularly if the 
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readers are experienced. [52] In their findings, there was high agreement between 
and within readers compared with other previous studies. They maintained that the 
large intra- and inter observer disagreements in previous studies were partially 
associated with lack of experience. [52]  
Dawson and colleagues, using CXR, demonstrated that independent readers were 
able to document with a substantial level of agreement, the presence of pulmonary 
radiological abnormalities consistent with TB. [53] They concluded that this was 
further validation of the CXR as a reliable tool for recording pulmonary 
radiographic abnormalities in its primary intended role as a screening tool in 
radiographic surveys. [53] 
However the studies above reflect imaging findings of TB in adults and cannot be 
translated directly to paediatric practice where the detection of lymphadenopathy 
for primary TB potentially poses an interpretational reader discrepancy. 
1.4.2. CT chest 
The ability of CT to demonstrate parenchymal lesions and lymphadenopathy far 
more accurately than CXR makes CT a more valuable diagnostic tool in small 
children with TB. [54] The efficacy of CT is particularly significant when CXR’s are
equivocal, or where complications related to tuberculosis are concerned. [54] The 
sensitivity of CT allows for a far superior identification and description of vague 
localised or disseminated parenchymal disease and mediastinal 
lymphadenopathy. [55, 56, 57] When comparing CXR and chest CT, the following 
results highlight the efficacy of CT. Correctly diagnosed TB on CXR is found in 
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approximately 49% of all cases, with 34% for primary TB and 59% in reactivation 
TB. [58] On CT however, 91% of patients had TB correctly diagnosed, while it was 
accurately eliminated in 76%. [59] Furthermore CT accurately distinguished active 
disease in 80%, and inactive TB in 89%. [59]  
 
The most frequently appreciated CT manifestations of PTB in small children 
include large mediastinal or hilar lymph nodes (often demonstrating necrosis in the 
centers) and mass-like air-space opacification with central break down or 
cavitation. [54] Diffuse pulmonary nodularity and airway involvement are also 
encountered. [54] High-resolution CT (HRCT) is valuable in identifying small 
cavities within areas of consolidation, dense nodularity or scarring. [55]  
 
HRCT is especially useful in the identification and characterisation of active TB in 
adults, founded on the nature of parenchymal opacities, cavities and/or 
endobronchial spread as represented by classic centrilobular nodularity or a ‘tree-
in-bud’ configuration. Lee et al. [59] accurately detected 80% of active TB and 
89% of inactive disease on HRCT.  
 
An additional advantage of CT is the ability to detect and further evaluate pleural 
disease and complications not always seen on CXR. These include TB effusions, 
empyema and bronchopleural fistulae. [60] Another advantage of CT is guiding the 
clinician toward the appropriate course of management, especially in cases of 
complicated or multi drug-resistant TB (MDR TB). [61] The presence of numerous 
cavities are often appreciated on CT in cases of MDR TB, which implies a large 
number of shedding bacilli with spread via the bronchi to unaffected areas of the 
ipsilateral and contralateral lung.  
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Poor penetration of drugs into the cavities harbouring many mycobacteria probably 
adds to drug resistance. Resection of these lesions is an option, although 
treatment mostly depends on pharmacotherapy. [61] If a surgical approach is 
warranted, CT provides an excellent surgical planning tool by showing the active 
disease and cavities. [61] 
 
A noteworthy disadvantage of CT in the paediatric population is the significant 
radiation dose of CT compared with the relatively low dose of CXR (PA and/ or 
lateral). Traditional CT radiation dose is equivalent to that of approximately 100 
CXR’s. [45] 
 
 1.4.3. MRI chest 
 
Peprah and colleagues used MRI on a limited group of older children with 
confirmed pulmonary TB. They distinguished between liquefactive necrosis, which 
has a high T2-weighted signal, and caseous necrosis, which has a low T2-
weighted signal within regions of lung parenchymal air-space disease. [62]  
 
Lymphadenopathy was found to have a characteristic T2-weighted low intensity on 
short Tau inversion recovery (STIR) sequences, likely related to paramagnetic free 
radicals associated with caseous necrosis. [45] TB lymphadenopathy was found to 
exhibit either solid nodular enhancement or rim enhancement (in the case of 
necrotic nodes) on MRI, similar to CT findings. [45] 
Irrespective of the imaging modality used to detect lymphadenopathy, enlarged 
nodes are relevant for treatment. [44] The general rule is that those with abnormal 
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nodes usually receive full duration anti-TB therapy, while those without CXR 
abnormality and a positive skin test only would be treated for latent infection. [44] 
 
1.5. Study Objectives 
1.5.1. Aim 
The aim is to identify simple and reliable CXR features of primary TB in children by 
determining the signs and anatomical sites of best observer agreement.  
1.5.2. Objectives 
The objectives are to: 
 - Determine agreement of three expert readers on the overall CXR diagnosis of 
PTB based on cumulative CXR features 
 - Determine the agreement of the three expert readers on lymphadenopathy 
causing airway compression overall and ‘best agreement’ at specific sites.  
 - Determine the agreement of the three expert readers on the presence of 
lymphadenopathy based on detecting soft tissue masses and best agreement at 
specific sites.  
 - Sub-categorise patients according to a majority decision into ‘severe’ and ‘non-
severe’ according to a current proposed classification of Wiseman et al. [63] and 
determine inter-observer agreement for this. 
 
2. Methods and Materials 
 
This is a retrospective descriptive study nested in a clinical trial performed under 
the auspices of the South African TB Vaccine Initiative (SATVI). Healthy BCG-
vaccinated newborn infants were monitored for at least two years for possible 
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incident pulmonary TB. A community surveillance system identified suspected 
paediatric TB on the strength of household adult TB contact or compatible 
symptoms (chronic cough, wheeze, weight loss, failing to thrive or unexplained 
pyrexia). 
All children with suspected TB were admitted for standardised TB investigation, 
which included a CXR. All original CXR’s were scanned using a high-quality 
radiography flatbed scanner and the images were stored in a database. Three 
independent blinded expert paediatric radiologists reported the CXR’s using a 
standardised data collection form on which the specific anatomical sites and signs 
of pathology consistent with pulmonary TB were recorded. 
These original data collection sheets were analysed in this study. The information 
of the first 200 patients was extracted from the records and analysed for the 
purpose of the current study. 
Each individual tick sheet from all three readers was scrutinised and the 
information was added into a specifically compiled data sheet from which the 
necessary information could be statistically calculated and extrapolated. In 
retrospect, after the data sheet was compiled only 199 patient information sheets 
were complete and eligible for analysis. The inclusion and exclusion criteria of 
both the original study and subsequent data sheet are outlined in the following 
paragraphs. 
 
2.1. Study Setting and sample size (original study) 
  
A study was undertaken in a high TB risk rural geographic region in Worcester, 
near Cape Town, South Africa. All told, 4786 infants were included, of whom 800 
children were investigated for TB, which included having CXR’s. 
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2.2. Inclusion criteria  
 
Healthy infants vaccinated with BCG (bacille Calmette-Guerin) were registered for 
the study within a fortnight of birth. These infants were randomly assigned to 3-
monthly TB screening questionnaires at home visits, as well as the checking of TB 
registers, hospital admissions and health facility CXR lists for suspected and 
confirmed cases of PTB. 
Overall 800 CXR's were performed and analysed by 3 independent expert readers 
(paediatric radiologists) from the City of Cape Town, South Africa. The findings 
were recorded on separate tick-sheets by the readers. The first 200 patients were 
selected for the nested study. In order to be eligible, all three readers’ tick-sheets 
were required to be present, with each patient only being entered once. 
2.3. Exclusion criteria 
 
Infants that did not receive BCG at birth or who were generally unwell or whose 
parents did not consent to participation or whose parents did not plan to remain in 
the study area for duration of the trial were excluded. 
Exclusion criteria for the nested study included incomplete, illegible, duplicated or 
incorrectly numbered tick-sheets. 
 
 




The data collection sheet included columns for the following: patient medical 
record number, case number, demographics (age at first admission in months, 
gender), lymphadenopathy (as identified by airway compression or soft tissue 
densities on frontal and lateral CXR projections by specific location), parenchymal/ 
airspace opacification (frontal and lateral projections by specific location), miliary 
TB, pleural effusions, cavitation and overall decision on the presence of PTB (see 
data collection tick sheet - Appendix A). 
Findings were only considered ‘present’ when recorded as ‘definitely present’. All
findings recorded as ‘maybe’ were considered with ‘negative’ as ‘not present’.
Data from the current tick sheets were collected for each reader under the 
following headings: 
- Overall decision of TB
- Overall decision on presence of miliary nodules
- Overall decision on lymphadenopathy
- Overall decision on presence of airway compression
- Overall decision on presence of soft tissue densities
- Decision of presence of above by each specific location
- Recording the decision of three readers together (based on majority as ‘present’
i.e. 2 or 3 readers positive = present)
- Presence of parenchymal / air-space disease overall
- Presence of right-sided parenchymal / air-space disease
- Presence of left-sided parenchymal /air-space disease
- Declared ‘unreadable’ film
Patients were categorised as ‘severe’ and ‘non- severe’ based on the majority of
the readers’ decisions, according to the published classification of Wiseman et al.
below. [63] 
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Classification of Intrathoracic Disease: 
‘Non-severe’ Disease:
A Ghon focus or non-expansile, non-bronchopneumonic single-lobe alveolar 
opacification seen on CXR, with or without uncomplicated intrathoracic lymph 
node disease, was classified as ‘non-severe’ disease. [63] Pleural fluid following
presumed breakdown of subpleural foci or due haematogenous dissemination was 
classified as ‘non-severe’ if there was no evidence of severe underlying lung
disease. [63] Classification followed after considering the presence and type of 
underlying lung disease and nature of the pleural fluid if a diagnostic tap has been 
completed. [63] In the case of an effusion obliterating radiographic visibility of the 
underlying lung, the disease could not be confidently classified. [63] It is noted that 
large effusions in young children (<5 years) are uncommon. [64, 65, 66, 67] More 
commonly small effusions overlying a peripheral Ghon focus are seen. [64, 65] In 
older children (>6 years), effusions may be large, obliterating visibility of the 
underlying lung. [65] 
‘Severe Disease’
Expansile alveolar opacification, tuberculous bronchopneumonia, multilobar 
alveolar opacification and cavitation all represent local complications and were 
classified as severe disease. [63] Complicated intrathoracic lymph node pathology, 
as in the presence of nodal compression of the large airways, was also classified 
as severe disease, regardless of whether disease was controlled or uncontrolled. 
[63] This includes the spectrum of endobronchial or lymphobronchial [68] disease
such as bronchial compression, a currently caseating lesion, granulomas, a 
polypoidal lesion or lymph node mucosal erosion and ulceration. [63] Although 
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these lesions are only observed during bronchoscopy, [69, 70] features of large 
airway compression can often be suspected based on CXR findings. [69] 
Empyaema (pus with or without TB mycobacteria in the pleural space) represents 
a disease complication, and was also classified as severe disease. [63] 
Tuberculous pericarditis was classified as severe disease, as it is felt to arise by 
spread from adjacent paratracheal, peribronchial, or subcarinal nodes (i.e. 
complicated disease), or from haematogenous bacillary spread. [71] If 
unrecognised, it may have severe sequelae, including death, due to its mechanical 
effects. 
2.5. Statistical analysis 
Readers were compared for features and sites of best agreement. Proportions and 
percentages of patients with severe and non-severe disease are presented. 
Subcategories of presence or absence of parenchymal/ air-space disease and 
readable or unreadable radiographs [as determined by majority] were created for 
comparison as confounding factors. Correlations were drawn between the 
categories and reader agreement. 
Kappa statistics were calculated for determining best agreement and categorised 
as follows by kappa value: 
Very good agreement 0.8 – 1
Good agreement 0.61 – 0.8
Moderate agreement 0.41 – 0.6
Fair agreement 0.21 – 0.4
 Poor agreement < 0.2 
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The kappa statistic calculates the kappa measure of inter-rater agreement (in this 
case for multiple raters (m>2) and two ratings (k=2)). We are testing whether the 
value (of kappa) is significantly different to zero. A p-value of < 0.05 in our study 
reflects the cut-off below which a finding is deemed unlikely to be random and is 
statistically significant. A small p-value rounded off to 0 (< 0.00005) is considered 
extremely statistically significant, therefore inferring that the occurrences are less 
likely to be by chance. Therefore in our study kappa statistics reflect strength of 
agreement whereas low p-values indicate the likelihood of the variation of the 
reader findings occurring due to non-random cause(s). 
 
2.6. Ethics approval 
 
The current study is nested within a SATVI trial, with clearance from the University 
of Cape Town research ethics board [Number: 064/2005]. No new imaging studies 
were performed or patient information gathered and used for the nested study. 






A total of 200 patients were sampled from 800 reviewed patient chest radiographs. 
1 patient was excluded from the data spreadsheet due to an administrative error, 
leaving 199 patients eligible for statistical analysis.  Of this total, 92 (46.23%) were 
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female and 107 (53.77%) were male. Gender frequency and percentage are 
summarised in table 3.1. 
Table 3.1. Frequency table for gender 
Gender (M/F) Frequency Percentage 
Female 92 46.23 
Male 107 53.77 
Total 199 100 
Age data are summarised in table 3.2. The median admission age was 14.03 
months. The minimum age was 2 months and the maximum age 36.6 months. No 
relationship or pattern between interpreted radiographic results and gender or age 
at admission was established i.e. the age and gender had no influence on the 
findings. 
Table 3.2. Distribution of age at admission (months) 
















Among the 199 eligible films reviewed by the three readers, the overall combined 
agreement for airway compression by presumed lymphadenopathy was 0.5%. A 
combined result of 5% of the radiographs were found to have a soft tissue mass 
likely reflecting lymphadenopathy on the frontal radiograph, as well as 5% on the 
lateral radiograph. Overall and individual reader interpretations of 
lymphadenopathy are summarised in Table 3.3. 
 
Reader 1 found CXR airway compression in 5%, Reader 2 in 0% and Reader 3 in 
0.5%. The most common site reflecting lymphadenopathy through airway 
compression was the left main bronchus. 
Soft tissue densities on the frontal projection were found in 20.6% of patients by 
Reader 1, 4% by Reader 2 and 3 % by Reader 3. Reader 1 noted soft tissue 
density on the lateral projection in 19% of patients, Reader 2 in 2.5% and Reader 
3 recorded 13%. Please refer Table 3.3. The majority of positive findings were in 
the right hilar region on the frontal projection and in the sub-carinal region on the 
lateral projection for all three readers. 
 
The p-values for overall agreement on lymphadenopathy resulting from airway 
compression and soft tissue densities on the lateral projection are 0.036 and 0.001 
respectively (more so for soft tissue densities). This infers high statistical 
significance, i.e. a high likelihood of non-random reader variability. The p-value of 
0 for soft tissue densities on the frontal projection suggests an extremely high 
likelihood of a non-random inter-reader variability. These are shown in Tables 3.9, 
3.10 and 3.11. 
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Table 3.3. Inter-reader interpretation of lymphadenopathy 

















































































































































None of the readers indicated the presence of a miliary parenchymal pattern. The 
overall combined agreement for air-space opacification on the frontal projection 
was 4.5% and on the lateral projection, 3.5%. The individual results reflect positive 
findings of air-space opacification on the frontal projection in 10.6% by Reader 1, 
6% by Reader 2 and 4% by Reader 3. 10% of radiographs were found to have air-
space opacification on the lateral projection by Reader 1, 4.5% by Reader 2 and 
2.5% by Reader 3.  
The area most agreed upon for all three readers in terms of air-space opacification 
on the frontal projection was the right lower zone. On the lateral projection, the 
bulk of positive findings were in the lower zone for Reader 1. Readers 2 and 3 
indicated their majority of positive findings in the right middle lobe. Overall and 
individual reader parenchymal findings are summarised in Table 3.4. 
 
The p-values for overall agreement on opacification on both frontal and lateral 
projections are rounded to 0, inferring significantly high probability that the 
variability of reader findings did not occur by chance. Refer Tables 3.12 and 3.13. 
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Table 3.4. Inter-reader interpretation of parenchymal opacification 
 




















































































































R1 = reader 1; R2 = reader 2; R3 = reader 3; OA = overall 
 
3.4. Cavitation and Pleural Effusion 
 
None of the readers indicated positive findings for cavitation or pleural effusion. 
Refer Table 3.5. 
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Table 3.5. Inter- reader interpretation of pleural effusions and cavitation 

































R1 = reader 1; R2 = reader 2; R3 = reader 3; OA = overall 
3.5. Overall Decision on PTB 
The overall findings reflecting PTB (lymphadenopathy or miliary) by each 
individual reader of the total number of CXR’s was 27.6% by Reader 1, 8.5% by
Reader 2 and 24,6% by Reader 3. The overall final decision on PTB agreed upon 
by all three readers was 14.57%. Refer Tables 3.6 and 3.7. 
Abnormal findings not specific for PTB were found in 3.5% of the CXR’s by Reader
1, 10.5% by Reader 2 and 3.5% by Reader 3. 
The overall cases reported as normal by all three readers were 98 out of the 199 
cases reviewed. The overall agreed upon number of radiographs reported as 
normal was 49.2%; refer table 3.8. 68.3% of the radiographs were reported as 
normal by Reader 1, 81.9% by Reader 2 and 66.8% by Reader 3. Refer Table 3.7. 
Therefore the number of cases found to have an abnormality by one or more of 
the readers, including those deemed unreadable by one or more readers, was 101  
out of the 199 cases reviewed, 50.7% 
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Table 3.6. Decision on PTB 
Final decision on PTB 
Variable Response Frequency Percentage 
Final Result 
0 170 85.43% 
1 29 14.57% 
0 = absent; 1 = present 
Table 3.7. Decision on PTB, abnormal and normal CXR 









































R1 = reader 1; R2 = reader 2; R3 = reader 3 
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The p-values for overall agreement on PTB and normal CXR’s were rounded to 0 
suggesting high likelihood of non-random cause for the variable reader findings, 
whereas the high p-values for abnormal CXR’s (not PTB) and unreadable films 






Table 3.8. Decision on normal CXR 
Final Decision on Normal CXR 
Variable Response Frequency Percentage 
Final Result 
0 101 50.7% 
1 98 49.2% 
 
3.6. Sub-categorising into severe and non-severe disease 
 
According to the combined findings of all three readers, none of the patients who 
were thought to have radiographic features of PTB met the criteria for severe PTB. 
These patients did however meet the criteria for non-severe PTB.  
 
3.7. Interobserver agreement 
 
35 
Interobserver agreement was determined for lymphadenopathy according to the 
presence of airway compression (table 3.9); lymphadenopathy according to soft 
tissue density on the frontal film (table 3.10); lymphadenopathy according to soft 
tissue density on the lateral film (table 3.11); final decision TB (table 3.12); 
parenchymal opacification on the frontal film (table 3.13) and parenchymal 
opacification on the lateral film (table 3.14). 
Table 3.9. Kappa results for airway compression due to presumed lymphadenopathy 
Lymphadenopathy: Airway compression 
Variable Kappa P-value
Rt Paratracheal Not able to calculate (all zero values) 
Rt Main Bronchus 0.1327 0.0006 
Bronchus Intermedius -0.017 0.6614 
Lt Main Bronchus 0.1523 0.0001 
Overall Agreement 0.0738 0.0356 
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Table 3.10. Kappa results for soft tissue densities due to presumed lymphadenopathy 
(Frontal) 
Lymphadenopathy: Soft tissue densities: frontal 
Variable Kappa P-value
Rt Paratracheal -0.0102 0.598 
Rt Hilar 0.265 0 
Rt Paracardial -0.0455 0.8671 
Lt Paratracheal -0.0034 0.5327 
Lt Hilar 0.1881 0 
Overall Agreement 0.219 0 
Table 3.11. Kappa results for soft tissue densities due to presumed lymphadenopathy 
(Lateral) 
Lymphadenopathy: Soft tissue densities: lateral 
Variable Kappa P-value
Pre-carinal 0.0258 0.2639 
Sub-carinal 0.1352 0.0005 
Behind Bronchus Intermedius 0.1788 0 
Overall Agreement 0.1261 0.001 
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Table 3.12. Kappa results for decision on PTB 
Final decision on PTB 
Variable Kappa P-value 
PTB (miliary/lymphadenopathy) 0.2595 0 
Abnormal but not PTB 0.0288 0.241 
Normal 0.3383 0 
Unreadable -0.017 0.6614 
 
Table 3.13. Kappa results for parenchymal/air-space opacification (Frontal) 
Opacification: Frontal 
Variable Kappa P-value 
Rt Upper Zone -0.0067 0.5655 
Rt Middle Zone -0.0136 0.63 
Rt Lower Zone 0.3715 0 
Lt Upper Zone Not able to calculate (all zero values) 
Lingula -0.0067 0.5655 
Lt Lower Zone 0.2553 0 




Table 3.14. Kappa Results for parenchymal/air-space opacification (Lateral) 
Opacification: Lateral 
Variable Kappa P-value
Upper Zone Not able to calculate (all zero values) 
Rt Middle Lobe 0.5762 0 
Lower Zone 0.0875 0.0163 
Overall Agreement 0.3139 0 
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Aim To review some of 
the important clinical 
and radiographic 
features of childhood 
tuberculosis 
To evaluate diagnostic  
criteria used for 
childhood TB at a 
primary health care 
facility in a high risk 
urban environment  
To assess inter- and 
intra-observer 
agreement in 
detection of large 
nodes by CXR in high 
risk children 
To identify simple 
and reliable CXR 
features of primary 
TB in children by 
determining signs 
and anatomical sites 





skin testkin test 
Sputum smear testing None None 
Conclusion Pulmonary infiltrates 
with  hilar and 
paratracheal nodes 
characterise primary 









guidelines were well; 
followed, but 
depended heavily on 
the CXR  
The interpretation of 
CXR’s is problematic, 
and its limited 
availability in most 
high-burden settings 
underscores the need 
for validated 
diagnostic guidelines 




children is detected on 
chest radiography with 




This suggests that the 
use of explicit criteria 
for lymphadenopathy 




The fair agreement 
amongst expert 
readers suggests 
that the CXR alone 
is not reliable in 
detecting pulmonary 
TB and should be 
combined with the 
clinical features, skin 
tests and blood 
results. 
 
The high agreement 
on normality makes 
the CXR a reliable 
tool for excluding 
disease. 
 
Soft tissue masses 
rather than airway 
compression are a 
more consistent sign 
of lymphadenopathy 
with the most agreed 
upon sites for 
detection being the 
right hilum followed 
by the left hilum, 




opacification is a 
relatively more 
reliable finding than 
lymphadenopathy 





[49, 47, 48] 
4. Discussion
This study addresses the inter-reader agreement of three expert readers on the 
presence of airway compression and soft tissue masses on CXR on the basis of 
presumed lymphadenopathy in children. The detection of lymphadenopathy on 
radiographs in an exposed population group of children is often used to diagnose 
PTB and has important consequences for anti-tuberculous medication. The study 
also addresses the agreement on the presence of air-space opacification not 
specific to tuberculosis, but rather as part of a constellation of features suggesting 
tuberculosis. An attempt was made to extrapolate the anatomical sites most 
reliable for the detection of lymphadenopathy according to the agreement of the 
three readers. Finally the study addresses the question as to whether PTB could 
be further sub-categorised into ‘severe’ and ‘non-severe’ on the basis of chest
radiograph features alone.  
The most reliable findings of lymphadenopathy on the CXR in our study were soft 
tissue densities reflecting presumed lymphadenopathy (kappa 0.219 -Table 3.10.), 
particularly at the right hilum (kappa 0.265 -Table 3.10.) and to a lesser extent the 
left hilum (kappa 0.19 -Table 3.10) on the frontal (AP) projection. Less reliable 
Unfortunately this 
study could not 
confirm the 
usefulness of CXR 
in subcategorising 
PTB into severe and 
non-severe due to 
the absence of any 
positive features for 
severe PTB in the 
selected sample  
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findings include soft tissue densities on the lateral projection and airway 
compression due to presumed lymphadenopathy. According to the kappa statistics 
the overall concurrence on combined decision on the presence of PTB was fair 
(kappa 0.26 -Table 3.12.). This supports the findings of Swingler and colleagues 
who showed only ‘‘fair’’ agreement between readers, worse so for lateral
projections. [44] Their patient group of children with suspected TB according to 
WHO criteria was similar to ours. Unlike our readers who had predefined tick-
sheets specifying features to be recorded, they did not set CXR reading 
parameters in advance. They suggest that accuracy could be improved by 
clarifying stipulations for lymphadenopathy on CXR [44], but the use of tick-sheets 
in our study has not had the expected impact. 
In our study the total number of cases found to have PTB as agreed upon by the 
readers was only 29 out of the 199 cases. However the number of normal 
radiographs agreed upon by all three readers was 98 of the 199 cases, almost half 
(49.2%); refer Table 3.8. These findings highlight the overall low prevalence of 
positive findings and the large number of normal findings in our study. Taking this 
into consideration, the calculated kappa statistics are somewhat unreliable. 
Illustrating this point is the relatively higher ratio of agreed upon positive PTB 
cases to abnormal chest radiographs, after excluding the agreed upon normal 
radiographs the sample (29 PTB cases of 101 abnormal cases, including those 
deemed unreadable by one of the readers). Therefore, as for Swingler and 
colleagues, we believe that in a population group which is more likely to have 
confirmed TB, the inter-reader agreement may be improved [44]. The fair number 
of agreed upon normal radiographs however, proves consensus on the exclusion 
42 
of any disease process. This is supported by the small p-value of normal CXR 
findings (Table 3.12) inferring high statistical significance. 
Considering the emphasis placed on the presence of airway compression for 
diagnosing lymphadenopathy, there was surprisingly poor agreement on the 
overall presence of airway compression due to presumed lymphadenopathy, 
including low reader agreement at the right and left main bronchi, and poor 
agreement at bronchus intermedius (Refer Table 3.9.). Overall, airway 
compression was present in only 5% of the patients (Table 3.3).  
According to the readers there were between 8.5% and 27.6 % of patients who 
had TB on X-ray (Refer table 3.7) with the percentage of these thought by those 
readers to have airway compression ranging from 0 – 5%. This is far lower than in
previous reports of paediatric TB, with lymph node-induced airway narrowing from 
35% [72] to 40% [73]. Either our sample is very different to those studies that may 
be reporting findings in very advanced cases of TB, or CXR is much less sensitive 
than CT for detecting this diagnostic feature and major complication. 
When compared with the study of duToit, Swingler and Iloni on the inter-observer 
variation in detection of lymphadenopathy on CXR (Refer to table 3.15) and using 
identical kappa criteria, our study observed similar ‘fair’ inter-observer agreement
with regards to overall detection of lymphadenopathy on CXR. [48] Interestingly, 
our study showed greater agreement on the absence of lymphadenopathy (kappa 
0.34 - Table 3.12) as opposed to presence of lymphadenopathy (kappa 0.219 –
Table 3.10) compared with the du Toit study where greater agreement was noted 
on the presence of lymphadenopathy. [48] This study also concluded that further 
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research is needed to find a reference standard to maximise validity and 
reproducibility in the detection of lymphadenopathy. This is similarly concluded in 
our study. 
 
Comparison made with the study by Theart, Marais, Gie et al found that although 
the diagnosis is dependent on the accurate interpretation of the CXR, combined 
clinical correlation is essential [47]. This is similar to our own findings which 
suggests that the CXR alone is not a reliable diagnostic tool for a paediatric 
population at high risk for pulmonary TB and ought to be used in conjunction with 
clinical features, skin tests and blood results. 
 
The remote study undertaken by Weber, Bird and Janower revealed that in 
addition to parenchymal disease, the paratracheal lymph nodes (particularly on the 
right) and bilateral hilar lymph nodes may be enlarged as seen by either bronchial 
compression or post obstructive atelectasis or emphysema. [49] Our study found 
that by using soft tissue densities, the right main bronchus (right hilum), followed 
by left main bronchus (left hilum) were the most agreed upon sites of detecting 
lymphadenopathy (refer table 3.10), similar to the Weber study [49]. In contrast to 
our low rate, a high incidence of right paratracheal lymphadenopathy (9 cases of 
the 23 cases positive for lymphadenopathy) [49] was found in the Weber study 
 
With regards to parenchymal opacification, the agreement according to kappa 
statistic was relatively higher than lymphadenopathy on both frontal and lateral 
projections, despite both only falling into the 'fair’ agreement category. The most 
agreed upon areas for detecting parenchymal opacities were the right lower zone 
on the frontal projection and lower zone and right middle lobe on the lateral 
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projection. From our study, it can therefore be deduced that the overall agreement 
on parenchymal opacification among the readers is relatively higher than for 
detecting lymphadenopathy and it can be inferred that the more reliable areas for 
appreciating parenchymal opacification are the right lower zone on the frontal 
view, and the right middle lobe and lower zone on the lateral. 
In view of the absence of any findings of miliary TB, pleural effusions and 
cavitation, all of the patients who were found to have PTB fell into the non-severe 
category as per the documented criteria. These results were found to be 
inconclusive, neither illustrating nor disproving the point that PTB can be further 
sub-characterised into severe and non-severe on chest radiograph. 
No relationship was established between the age and gender of the patients and 
the presence of active PTB. Considering that the median age was 14.03 months, 
with a minimum of 2 months and a maximum of 36.6 months at first admission, the 
findings of this study are not necessarily true for children older than this (Table 
3.2.). The findings are therefore also not comparable to those of Swaminathan and 
colleagues who only reported on children from 6 to 12 years with clinical features 
of tuberculosis, and demonstrated that a significant proportion of children with 
positive cultures had normal chest X-rays. [23] 
An important study limitation is the absence of a validated reference system for 
lymphadenopathy. Current practice norms were used in the assessment of 
detection of nodes in this study. The large number of negative findings (normal 
CXR’s) within the randomly selected sample of patients hampered the study. Of
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the 200 patient CXR's selected from the sample of 800, 1 selected patient was 
excluded from the spreadsheet due to an administrative error. 
5. Conclusion
The low agreement amongst expert readers suggests that the CXR alone is not a 
reliable tool in detecting paediatric pulmonary TB and should be used in 
conjunction with the clinical features and/or skin tests and blood results. The fair 
agreement on normal chest radiographs makes the CXR a fairly reliable tool for 
excluding disease. 
Soft tissue masses rather than airway compression are a more reliable sign for 
lymphadenopathy and the most agreed upon sites for detection are the right hilum 
followed by the left hilum on the frontal projection. 
Parenchymal opacification is a relatively more reliable finding than 
lymphadenopathy according to better overall agreement among readers. 
Unfortunately this study could not confirm the usefulness of CXR in 
subcategorising of PTB into severe and non-severe due to the absence of positive 
features for severe PTB in the selected sample. The use of prescribed tick-sheets 
with specified features for detecting lymphadenopathy did not have the expected 
impact of promoting agreement between observers in the interpretation of CXR’s
in children with suspected TB. The absence of a credible reference standard for 
lymphadenopathy remains a significant limitation. 
Further research comparison with an imaging gold standard can pave the way for 
setting more accurate X-ray criteria both for improving sensitivity and specificity 
with improved inter-reader agreement in the diagnosis of paediatric TB. The CXR 
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may be more useful in children with more severe clinical presentations where CXR 
findings may be more obvious or occur more frequently. 
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